AgapePress - "How many more deaths?" That's the question that pro-lifers are asking following the latest reports of more deaths that may be attributable to the abortion pill known as RU 486, which the federal government approved for distribution amidst political accusations shortly before Bill Clinton left office.
Danco Laboratories, which markets RU 486 (a.k.a. "Mifepristone") in the United States, announced to the Food and Drug Administration on Friday that two more women died recently after taking RU 486, the first of two drugs taken to abort an unborn child chemically. That brings the number of deaths in the U.S. to at least seven women after taking the two-step regimen since it was approved by the FDA in September 2000.
The federal agency's response following these latest reports? Convene a workshop for early May to discuss research on the infection that killed four of the women last July.
And instead of yanking the drug it approved in the waning days of the Clinton administration, the FDA has issued a statement saying it is investigating the circumstances of the deaths. "All providers of medical abortion and their patients need to be aware of the specific circumstances and directions for use of this drug and all risks including sepsis when considering treatment," states the agency website. "In particular, physicians and their patients should fully discuss early potential signs and symptoms that may warrant immediate medical evaluation."
The FDA's response has triggered outrage from the halls of Congress to the offices of pro-life groups, with criticism beginning with variations on the phrase: How many more deaths will it take?
No comments:
Post a Comment